Review
Copyright ©The Author(s) 2020.
World J Gastroenterol. Apr 14, 2020; 26(14): 1580-1593
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1580
Table 3 Targeting gastrointestinal cancer stem cell by natural killer cells, chimeric antigen receptor expressed on T cells and dendritic cells based vaccines
Targeting approachCancer modelRef.
CIK cells via NKG2D ligands expressed on CSCHepatocellular carcinoma[56]
NK cells via NKG2D ligands expressed on CSCPancreatic cancer[57]
CAR-T for CSC antigen ASB4Colon cancer[59]
CAR-T for EGFR and CAR-T for CSC antigen CD133Cholangiocarcinoma[60]
CAR-T for CSC antigen CD24Pancreatic adenocarcinoma[61]
DC loaded with Panc-1 CSC lysatePancreatic cancer[62]
DC loaded with total mRNA from gastric CSCGastric cancer[63]